Sanofi (SAN) defended its experimental drug Lyxumia after some scientists questioned the medicines novelty at a diabetes conference. Lyxumia isnt at all an imitation of Bristol-Myers Squibb Co. (BMY)s…
Genzyme a Sanofi company EURONEXT SAN and NYSE SNY today announced that ENGAGE the first Phase 3 trial of its investigational oral therapy eliglustat tartrate in previously untreated…
Sanofi (SAN) says pressing ahead with a plan to reorganize drug research in France is critical. So is caution in a country on the brink of labor unrest. Chief Executive Officer Chris Viehbacher, speak…
Sanofi (SAN)s experimental shot against dengue protected against three of the deadly viruss four strains in the first test of a vaccine against the most common mosquito-borne disease. In a trial among…
